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The prevalence of diabetes is rapidly rising all 
over the globe at an alarming rate[1] so also is 
the number of diabetic mellitus (DM) patients 
with diabetic neuropathy (DN) as it is estimated 
that about 45 % of patients with DM will develop 
diabetic polyneuropathy (DPN).[2] If not attended 
to, DPN may cause serious complications, such 
as diabetic ulcers, gangrene, and Charcot joint, 
with attendant negative effect on the quality of 
life in diabetic patients.[3] DN is a frequent 
microvascular complication of DM, and 
represents an insidious process for which a 
disconnection may exist between development 
of symptoms and signs, and its pathological 
severity.[4] 
ABSTRACT 
Background: Diabetic neuropathy (DN) is a potentially debilitating complication of diabetes mellitus 
but many of the diabetic patients are often asymptomatic of DN, thereby, placing them at high risk of 
developing debilitating complications like diabetic hand and foot. Aim: The study was designed to 
evaluate median nerve conduction of T2DM patients that were asymptomatic for neuropathy and 
compare their findings with age and sex-matched healthy individuals. Methods: The median motor 
and sensory nerve conduction study was conducted on 100 type 2 diabetic (T2DM) patients and 100 
healthy volunteers, matched for age and sex-matched control. Median nerve motor and sensory 
proximal and Distal latency (DL), Amplitude and Conduction Velocity (CV) as well as motor f-reponse 
were measured using Nihoen Kohden EMG Machine and standardized techniques of measurement in 
the course of the study were adhered to. Results: On comparison of the median nerve motor and 
sensory parameters, the median nerve (motor and sensory) distal latencies and f-responses were 
significantly lower in the control group while the median nerve conduction velocities and amplitudes 
were significantly higher in the T2DM group. Conclusion: The study showed significant impairment of 
median nerve conduction parameters in T2DM patients who did not have any feature suggestive of 
peripheral neuropathy when compared with apparently healthy individuals. Thus high index of 
suspicion as well as early screening for peripheral neuropathy in diabetes is further emphasized. 
Key words: Median nerve, diabetic neuropathy, electrodiagnostic evaluation, conduction velocity, 
latency 
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The signs, symptoms, and neurologic deficits in 
DN vary depending on the classes of nerve 
fibers involved. Neuropathies may be either 
sensory or motor [5,6,7] and may involve primarily 
small or large nerve fibers.[8]  Diabetic 
sensorimotor polyneuropathy is the most 
common clinical subtype seen in clinical 
practice.[6,7] It is, potentially, the most debilitating 
of the complications as manyof the patients are 
often asymptomatic of neuropathy, thus, placing 
them at high risk of developingdevastating hand 
and foot complications before they present with 
overt symptoms of diabetic neuropathy.[9] 
 
In the developed countries, nerve conductions 
study is widely used for the assessment of DN 
for detection of the abnormality, evaluate the 
degree of abnormality and monitoring the clinical 
course of the disease. Symptoms of DN usually 
develop at any degree of neuropathic 
impairment or may not develop at all.[7] 
Therefore, there is need to conduct Nerve 
conduction studies (NCS) whenever DN is 
suspected as early and precise detection of DN 
will facilitate early intervention and prevent the 
crippling complication of DN. 
 
In spite of the rising prevalence of DM and DN in 
developing countries, there is scarcity of 
electrodiagnostic facilities necessitating reliance 
on less specific and less sensitive screening 
tools like the United Kingdom screening test 
(UKST) for diagnosis.[10,11] NCS  are more 
sensitive than clinical examinations as the later 
does not offer quantitative results and the NCS 
are the least variable and non-invasive means of 
evaluating neuropathy.[12] 
 
The study was designed to evaluate median 
nerve conduction inT2DM patients who were 
asymptomatic for neuropathy and compare their 





The data was collected over a six-month period 
at the neuro-diagnostic laboratory of the Aminu 
Kano Teaching Hospital (AKTH), Bayero 
University, Kano, Nigeria. One hundred T2DM 
patients without features suggestive of DN and 
100 age and sex-matched control were recruited 
in the study. The cases were already but 
recently diagnosed T2DM, on treatment, 
recruited from the diabetic clinics of the AKTH, 
Murtala Muhammad Specialist Hospital (MMSH) 
and other peripheral hospitals. Diagnosis of DM 
was made by consultant endocrinologists and 
senior residents in endocrine and metabolic unit 
in all cases.  
 
All the participants with features of neuropathy, 
chronic musculoskeletal disorders, thyroid 
disorder, leprosy, other chronic systemic 
disease, alcoholics, smokers and pregnancy 
were excluded from the study. Neurological 
examination was done to determine muscle 
power, stretch reflexes and sensations.  
 
The NCS study was performed with the patients 
and control lying comfortably in the supine 
position. A standardized technique was used to 
obtain and record action potentials for motor and 
sensory functions.[13] The protocol adopted in the 
current study was similar to that used by 
Kimura[13]and Hamdan[14] with minor alteration. 
The setting for a 4-channel electromyography 
machine (Nihoen Kohden) machine used in the 
study was as follows: for median motor nerve 
conduction, the low cut filter was 2–5 Hz and the 
high cut was 10 KHz.[13] Regarding sensory 
median nerve conduction, low cut was set at 5–
10 Hz, high cut was set at 2–3 KHz; the 
amplification between 20,000 and 100,000 
times; electrode impedance was kept below 5 
kΩ and the sweep speed for sensory nerve 
conduction was maintained at1–2 ms/ division 
while for motor nerve conduction: 2–5 ms/ 
division; and a stimulus duration of 50 μs to 
1000 μs and current 0–50 mA are required for 
effective nerve stimulation.[13] Supramaximal 
stimulation (20%–30% more than the current 
required for maximal action potential) was 
used.[13] The NCS evaluation was conducted on 
their left hands. 
 
Data was collected for proximal and distal 
latency measured from the onset of action 
potential, conduction velocity, and amplitude of 
compound muscle action potential (CMAPA) and 
sensory nerve action potential (SNAPA) were 
measured from positive peak to the trough of the 
action potentials.[13,14] All the studies were 
performed with surface recordings and 
stimulations. 
 
Proximal median nerve stimulation was 
performed medial to biceps brachii tendon at the 
elbow crease while the distal median 
stimulations were performed 10-13 cm proximal 
to the active surface electrode.[13]   
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The Median motor nerve was examined 
orthodromically.  The nerve was stimulated with 
bipolar surface stimulating electrode at two 
points along its course.[13]  The action potential 
was recorded with active and reference surfaces 
placed close to the motor point of Abductor 
Policis Brevis and thumb respectively in the 
case of motor and both electrodes on the first 
finger in the case of sensory component of the 
nerve.A ground electrode was placed between 
the stimulating and recording electrodes.[13] The 
motor nerve conduction velocity (MNCV) was 
calculated using the distance between points of 
two stimulations by the difference between their 
latencies.[13] Sensory nerve conduction was 
measured antidromically. The sensory nerve 
conduction velocity (SNCV) was measured by 
stimulating a single site. Skin surface 
temperatures were measured over the dorsum 
of the hand.[14]   
 
Ethical approval was obtained from the ethical 
review committee of the Aminu Kano Teaching 
Hospital Kano. Informed consent was obtained 
from each participant. 
 
Statistical analysis 
All the data generated were collated, checked 
and analyzed using GraphPad Prism (version 6, 
GraphPad Software, Inc. CA 92037 USA). 
Quantitative variables were described using 
mean with standard deviation and median with 
range in the case of parametric and non-
parametric data respectively. Student t-test and 
Man Whitney test were used for parametric and 
non-parametric data respectively for the 
comparison of nerve conduction parameters 
between T2DM and control based onnormality of 
the data obtained in various situations.  P-value 




A total of 100 T2DM patients, who were 
matched with 100 healthy volunteers by age and 
sex, comprised fifty eight (58%) males and forty 
two (42%) females. Their mean age was 49yrs + 
19 years. The average duration of T2DM was 
2.32 ± 0.83 years. 
 
The median value of median nerve velocities 
(motor) with their 95% confidence intervals were 
47.7m/s (45.8-50.63), 63.9m/s (62.0-63.9) in 
T2DM and control respectively (P<0.0001). The 
median values of the median nerve distal  
latencies (motor) with their 95% confidence 
interval were 3.2ms (3.1-3.3), 3.0 ms (3.0-3.2) in 
T2DM and control respectively (P=0.0366). The 
median values of median nerve distal 
amplitudes (motor) with their 95% confidence 
interval were 5.5 mv (5.3-6.1), 7.4 mv (7.3-8.1) 
inT2DM and control respectively (P<0.0001).  
Minimal F-response latencies were 33.7 ms, 
95% CI (33.13-35.56) and 27.5, 95% CI (26.4-
28.1) respectively (figure 1). 
 
Regarding the sensory component of the 
median nerve, the median values of median 
nerve velocities (sensory) with their 95% 
confidence interval were 32.2m/s (28.0-34.6) 
and 58.5 m/s (58.2-60.8) in T2DM and control 
respectively (P<0.0001). The median values of 
the median nerve distal latencies (motor) with 
their 95% confidence interval were 5.8ms (4.9-
5.6) and 2.9 ms (2.8-3.0) in T2DM and control 
respectively (P=0.0366). The mean values of 
median nerve distal amplitudes (motor) with their 
95% confidence interval were 5.7 mv (5.6-6.8) 
and 7.9 mv (7.5-8.5) in T2DM and control 




The current study showed significant impairment 
of median nerve conduction parameters in 
T2DM patients without subjective features 
suggestive of peripheral neuropathy when 
compared with apparently healthy individuals. 
The result obtained in our study further 
corroborated the reports from previous studies 
that showed median nerve sensorimotor 
dysfunctions in T2DM patients.[15-21] 
 
The mechanisms underlying disturbance of 
nerve conduction in diabetes include metabolic, 
vascular, autoimmune, and neuro-hormonal 
growth factor deficiency. Nonetheless, the 
prevailing theory suggests persistent 
hyperglycemia as the primary factor of the 
metabolic hypothesis.[22] Uncontrolled 
hyperglycemia increases polyol pathway activity 
with accumulation of sorbitol and fructose in 
nerves, damaging them by a yet unknown 
mechanism.[22] This is accompanied by 
decreased myo-inositol uptake and inhibition of 
the Na+/K+-adenosine triphosphate with 
attendant retention of Na+, edema, myelin 
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Figure 1: Comparison of median (motor) nerve conduction parameters in DM patients and matched 
control. It showed significant difference nerve conduction parameters of the median nerve in type-2 




Owolabi et al.: Median nerve conduction in Type II diabetes mellitus 







Figure 2: Comparison of median (sensory) nerve conduction parameters in DM patients and matched 
control. It showed significant difference nerve conduction parameters of the median nerve (sensory) in 
type-2 DM and matched control (a-c) 
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Nerve conduction studies are the most objective, 
accurate, and reliable method for detecting 
DPN.[24] DPN is associated with changes in both 
nerve conduction velocity and amplitude.[24] 
Patients with DPN are often asymptomatic and 
monofilament and vibration perception may 
appear normal despite substantial nerve fiber 
degeneration.[24] Consequently, traditional 
clinical approaches are, to a large extent, 
insensitive to subclinical or minimal 
neuropathy.[25] It is therefore not uncommon to 
see some patients present with hand or foot 
ulcers without a prior diagnosis of DPN.[26] Thus, 
patients with DPN may go undiagnosedand 
opportunities to commence early preventative 
measures and patient education on proper hand 
and foot care are missed.[24] 
 
Our study revealed significant deterioration in 
motor function in the T2DM group with reduced 
velocity and amplitude and prolonged distal 
latency when compared with the control group. 
This finding is in conformity with the reports of 
the previous workers.[27,28]. Similarly, the present 
study showed significant sensory function 
deterioration evident by reduced velocity and 
amplitude and prolonged distal latency in the 
diabetic group in comparison with the control 
group and the observed difference was much 
more pronounced in the sensory nerves.  
 
This finding agreed with the notion that DPN 
may start very early in diabetic patients and that 
it often involves the sensory fibers initially.[12,18] 
However, few studies reported the contrary. 
Sultana et al.[12] and Biswas[28] in separate 
studies reported deterioration of motor nerve 
function without sensory nerve dysfunction in 
T2DM. In another study by Bhomwhik,[29] 
involving less than 30 newly diagnosed diabetic 
patients, motor abnormality was predominantly 
found. The departure of their findings from our 
observations and those of several other 
researchers[15-20] may be explained by the 
relatively small sample size in their studies. 
 
Reduction in median NCV, which is commonly 
present even at diagnosis, is one of the earliest 
neuropathic abnormalities in DM especially in 
patients with T2DM.[30,31]  In fact, it has been 
shown that following diagnosis of DM, slowing of 
median NCV usually progresses at a steady rate 
by approximately 1 m/s/yr, and that there is 
positive correlation between the level of 
impairment and duration of DM.[31] The early 
impairment of nerve conduction study 
parameters observed in T2DM probably account 
for the difficulty in terms of restoration of function 
following intervention late in the disease 
process. Since sensory fibers are often the first 
to be affected, for early intervention to be 
possible and fruitful,[15] there is a need for high 
index of suspicion and early nerve conduction 
measures of sensory function. 
 
In agreement with reports of previous studies,[15-
20] the current study suggests that impairment of 
nerve conduction may be present in T2DM even 
in the absence of complaints by the patients and 
absence of impairment on routine neurological 
examinations. Although slowing of median NCVs 
and prolonged distal latencies, which often 
occurs early in the course of the disorder, are 
rife in T2DM, the relevance of these 
abnormalities to the future development of either 
subclinical manifestations or clinically apparent 
diabetic neuropathy is still largely uncertain[23]as 
NCV does not appear to be related to the 




To the best of our knowledge, the current study 
is the first in Nigeria to comparatively assess 
median nerve conduction status in T2DM using 
an electromyography machine rather than a 
questionnaire-based screening instrument. We 
strongly believe that the findings in the study will 
contribute to the knowledge-base in respect of 
median nerve neuropathy in T2DM with the view 
to emphasizing on early screening, detection 
and prompt therapeutic intervention in people 
with or without symptoms of diabetic 
neuropathy. The study has demonstrated that 
there is significant impairment of median nerve 
conduction parameters in T2DM patients without 
subjective features suggestive of peripheral 
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